Zhongping Capital
Overview
Zhongping Capital is a leading alternative asset manager in China . The firm invests across finance services, TMT, healthcare, environmental services, new energy, and Industry 4.0 . Zhongping aims to create long-term value for its investors by adopting a patient “buy-and-hold” investment approach and helping its portfolio companies achieve their full potential with implementation of growth and best-practice operational strategies . Zhongping Capital incorporates ESG principles into its corporate strategy and the entire investment decision-making process, continuously contributing to the high-quality development of China's economy .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Tripo AI | Sep 2026 | Series B | Co-investor |
| Cascade Pharmaceuticals, Inc. | Feb 2026 | VC Round | Lead |
| Bluepha | Feb 2023 | Series B Extension | Lead |
| Shanghai Golden Leaf Med Tech Co., Ltd. | Mar 2024 | Series D | Lead |
| Shanghai Kingstar Fintech Co., Ltd. | Mar 2018 | Buyout/LBO | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Zhongping Capital based?
Zhongping Capital is headquartered in Shanghai, Shanghai, China.
When was Zhongping Capital founded?
Zhongping Capital was founded in 2016.
How many portfolio companies does Zhongping Capital have?
Zhongping Capital has 8 portfolio companies in Caplight's dataset.
What are some companies in Zhongping Capital's portfolio?
Portfolio companies visible on Caplight include Tripo AI, Cascade Pharmaceuticals, Inc., Bluepha, Shanghai Golden Leaf Med Tech Co., Ltd., Shanghai Kingstar Fintech Co., Ltd..
What was Zhongping Capital's most recent investment shown here?
Zhongping Capital's most recent investment in this portfolio sample was in Tripo AI in 2026.
What sectors does Zhongping Capital focus on?
Zhongping Capital focuses on Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Healthcare & Life Sciences, Energy & Sustainability, AI, Data & Cloud Infrastructure, Media, Entertainment & Gaming, Energy & Sustainability, Mobility, Transportation & Logistics, Enterprise Software, Frontier & Industrial Tech.
What company stages does Zhongping Capital focus on?
Stage focus information for Zhongping Capital is not publicly available.
What is Zhongping Capital's AUM?
Zhongping Capital's assets under management are estimated between $250.0M and $500.0M.